ReviewJACS Au2026
Trends and Challenges in Multistep Continuous Flow Synthesis.
Review in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flow chemistry has become an important tool for manufacturing nowadays, driven by the growing demand for safety, efficiency, scale, and sustainability in chemical industries. Building on basic flow chemistry techniques, multistep continuous flow synthesis has emerged as an attractive synthetic process in pharmaceutical, agricultural, and materials synthesis. In practice, numerous issues need to be addressed in multistep continuous flow processes, such as reaction compatibility, step-connection, material transfer, and flow stability. Aiming to establish an industrially viable multistep flow process for tiadinil, methiadinil, emamectin benzoate and other drug molecules in agricultural and pharmaceutical industry, we cooperated with enterprises in the past few years and encountered nearly all the difficulties that may arise in the process, and these difficulties are also long-standing challenges for industry settings. To tackle these barriers faced, we developed and searched for various solutions to address them. These practices further facilitated the formulation of the common solutions for developing a multistep continuous flow process. This perspective will integrate relevant literature with our research to showcase the key challenges in multistep continuous flow synthesis and discuss corresponding solutions. Additionally, general development of flow process usually begins with extensive screenings of reaction conditions in batch before further optimization in flow. Instead, a more efficient approach called de novo flow, defined as performing reaction optimizations primarily in flow after feasibility has been established in batch, has been emerging as a viable strategy. We also present an outlook on the forthcoming development of multistep continuous flow synthesis and point out the key issues to be addressed in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.